Dynex Capital, Inc. Declares Common and Preferred Stock Dividends

GLEN ALLEN, Va.--(BUSINESS WIRE)-- Dynex Capital, Inc. announced today that the Company’s Board of Directors has declared a cash dividend of $0.15 per share on its Common Stock (NYSE: DX) for December 2024 and the quarterly cash dividend of $0.43125 per share of its 6.900% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (NYSE: DXPRC) for the fourth quarter of 2024.

The Common dividend is payable on January 7, 2025, to shareholders of record as of January 2, 2025. The Preferred dividend is payable on January 15, 2025, to shareholders of record as of January 1, 2025.

About Dynex Capital

Dynex Capital, Inc. is a financial services company committed to ethical stewardship of stakeholders' capital; employing comprehensive risk management and disciplined capital allocation to generate dividend income and long-term total returns through the diversified financing of real estate assets in the United States. Dynex operates as a REIT and is internally managed to maximize stakeholder alignment. Additional information about Dynex Capital, Inc. is available at www.dynexcapital.com.

Forward Looking Statement

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding the business of Dynex Capital, Inc. that are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of these risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s Annual Report on Form 10-K and other reports filed with the Securities and Exchange Commission.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241211456666/en/

Alison Griffin
804-217-5897

Source: Dynex Capital, Inc.

You May Also Be Interested In

• Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings
• West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation
• Bandwidth Achieves ISO/IEC 42001 Certification for AI Management System, Reinforcing Leadership in Trusted AI Infrastructure